Die Anzahl der Infektionen mit dem neuen Coronavirus nimmt in der Schweiz wieder zu. Die SGI verfolgt die nationalen und internationalen Entwicklungen mit grösster Aufmerksamkeit und nimmt die Lage aufgrund der bisherigen Erfahrungen ernst.
Die Verbreitung des Corona Virus hat unser Leben auf den Kopf gestellt und die aktuelle Situation beschäftigt sehr viele Menschen. Es stellen sich Herausforderungen, auf die wir uns kaum vorbereiten konnten: als Betroffene, als Angehörige, als Gesundheitsfachpersonen aber auch als Eltern und Familien. Hier gibt es ein Angebot für Menschen, die in dieser schwierigen Zeit ein Gespräch benötigen.
Nähere Informationen finden Sie auf der Webseite oder dem Flyer.
many new information, updates and webinars regarding pediatric and neonatal intensive care can be found: www.espnic.eu
ANZICS
The Australian and New Zealand Society of Intensive Care Society (ANZICS) has released guidelines for the management of COVID-19 from the intensive care perspective.
The Society of Critical Care Medicine (SCCM) has launched an online training resource for those responding to the COVID-19 pandemic. The number of patients requiring hospital admission is expected to surge which may require the need for non-ICU clinicians to care for critically ill patients.
Critical Care for the non-ICU Clinician provides free online education for healthcare professionals who could benefit from critical care training. This is free training for Non-ICU Clinicians to help them get prepared.
Updates from the EMA The European Commission and the Head of Medicines Agencies (EMA) support the development and approval of vaccines and treatments for COVID-19 under its recently activated plan for managing emerging health threat. Consult EMA's special coronavirus disease (COVID-19) website for frequent updates.
Today, we would like to highlight the following EMA updates:
EU PAS Register for 'COVID-19' studies 27 March 2020: Researchers are encouraged to register their pharmacoepidemiological studies related to the COVID-19 pandemic in the EU PAS Register, including a study protocol and description of the collected data. 'COVID-19' should be included in the title to allow easy retrieval by others.
Guidance on methodological aspects of ongoing clinical trials during COVID-19 25 March 2020: EMA published guidance to help ensure the integrity of their studies and the interpretation of study results while safeguarding the safety of trial participants as a first priority. This Guidance on methodological aspects of ongoing clinical trials during COVID-19 complements the above highlighted guidelines for the management of clinical studies during COVID-19.